Clinical Trials Browser

Phase 4 × Not yet recruiting × INDUSTRY × Clear all

NCT07569926 2026-06-02

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Phase 4 Not yet recruiting

Prostatic Neoplasms

NCT07609940 2026-05-27

POPLIN

Phase 4 Not yet recruiting

Cytokine Release Syndrome, Multiple Myeloma

NCT07469202 2026-03-13

CYTALUX Dose Extension Study

Phase 4 Not yet recruiting

GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms

NCT07459543 2026-03-09

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

Phase 4 Not yet recruiting

Melanoma, Skin Neoplasms

NCT07357597 2026-01-22

TROPION-SWISH

Phase 4 Not yet recruiting

Stomatitis

NCT07247162 2025-12-10

LINC CARE

Phase 4 Not yet recruiting

ACTH Syndrome, Ectopic, Cushing Syndrome, Hypertension

NCT06290765 2025-07-31

PV

Phase 4 Not yet recruiting

Myeloproliferative Disorders, Polycythemia Vera

NCT06897527 2025-07-08

A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

Phase 4 Not yet recruiting

Endometrial Neoplasms

NCT06887933 2025-03-21

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

Phase 4 Not yet recruiting

Ovarian Neoplasms

NCT06613373 2024-09-25

An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms

NCT06047535 2023-09-21

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.

Phase 4 Not yet recruiting

Neuroblastoma

NCT05367765 2022-05-10

A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Phase 4 Not yet recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase